Oral Drug Slows Stargardt Disease Progression in Phase 2 Clinical Trial
Tuesday, March 5 2024 | 08 h 05 min | Vision Science & Research
Results from a Phase 2 clinical trial show that an oral drug, Tinlarebant, may slow progression of Stargardt disease Belite Bio, a...
Read MoreVitamin A Supplements do not Improve Vision for Individuals with Retinitis Pigmentosa
Wednesday, February 21 2024 | 07 h 53 min | Vision Science & Research
A new study from Dr Eric Pierce and Dr Jason Comander at Mass Eye and Ear does not show any benefit to taking high-dose vitamin A supplements for...
Read MoreRetina Can Predict the Path of Moving Objects
Wednesday, January 5 2022 | 09 h 07 min | Vision Science
Researchers at the University of Washington have shown that the retina can create the information needed to predict the path of a moving object...
Read MoreFight the Leading Cause of Working Age Blindness: Diabetes
Monday, December 13 2021 | 10 h 52 min | News, Press Release, Vision Science
In Canada, someone is diagnosed with diabetes every three minutes A diabetes diagnosis holds many implications for a person: it impacts a...
Read MoreSupporting Vision Researchers of Tomorrow
Friday, December 3 2021 | 10 h 40 min | Awards, Events, News
Fighting Blindness Canada’s inaugural vision research competition, ‘Eye on the Cure presented by FYidoctors’, premiered on Saturday, November...
Read More